and it’s used for certain types of advanced ovarian cancer. Pembrolizumab is given as an IV infusion every three weeks. Side effects include fatigue, nausea, cough, itching, skin rash ...

Several cancers, including ovarian, cervical, testicular, kidney, and lung, often present no early symptoms, leading to ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before detection. Risk factors include age, obesity, genetics, and hormone therapy.

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...